| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |